Vaccine partnership raises hope for millions

(Griffith University) Griffith University will partner with a Chinese pharmaceutical, Olymvax Biopharmaceuticals Inc. for a new vaccine that could benefit millions.Researchers from Griffith University's Institute for Glycomics have announced that they will begin Phase 1 clinical trials on a new, needle-free vaccine targeted at Streptococcus A infection, the cause of strep throat and rheumatic heart disease.